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Abstract—Deep learning, through the use of neural networks,
has demonstrated remarkable ability to automate many routine
tasks when presented with sufficient data for training. The
neural network architecture (e.g. number of layers, types of
layers, connections between layers, etc.) plays a critical role in
determining what, if anything, the neural network is able to
learn from the training data. The trend for neural network
architectures, especially those trained on ImageNet, has been
to grow ever deeper and more complex. The result has been
ever increasing accuracy on benchmark datasets with the cost
of increased computational demands. In this paper we demon-
strate that neural network architectures can be automatically
generated, tailored for a specific application, with dual objectives:
accuracy of prediction and speed of prediction. Using MENNDL–
an HPC-enabled software stack for neural architecture search–we
generate a neural network with comparable accuracy to state-of-
the-art networks on a cancer pathology dataset that is also 16×
faster at inference. The speedup in inference is necessary because
of the volume and velocity of cancer pathology data; specifically,
the previous state-of-the-art networks are too slow for individual
researchers without access to HPC systems to keep pace with
the rate of data generation. Our new model enables researchers
with modest computational resources to analyze newly generated
data faster than it is collected.
Index Terms—evolutionary algorithms, multi-objective opti-
mization, high performance computing, neural networks
I. INTRODUCTION
Many scientific research applications rely on the analy-
sis of imagery produced using specialized instruments such
as microscopes. Scientific data analysis can be accelerated
through effective use of automation techniques such as deep
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learning. There are two obstacles for effective deployment
of deep learning for scientific data analysis. First, scientific
data does not often share characteristics with standard datasets
(such as ImageNet). As such, deep learning models optimized
for standard datasets are not always ideal for novel scientific
datasets. Second, the volume and velocity of scientific data
production necessitate models that can make very fast and
accurate predictions. Because of these unique challenges,
tailoring neural network architectures for a specific dataset
is often necessary. Even with human guided design, design-
ing deep networks for fast and accurate predictions can be
computationally expensive and time-consuming.
In this work, we demonstrate a software framework called
Multinode Evolutionary Neural Networks for Deep Learning
(MENNDL) that utilizes high-performance computing (HPC)
to automate the design of deep learning networks in order
to analyze cancer pathology images. MENNDL effectively
parallelizes and scales the evaluation of millions of networks
within hours, utilizing the computational power of a GPU-
based HPC system. Here, we have enhanced MENNDL to
allow for multi-objective optimization, so that factors such as
prediction time are explicitly included as objectives during the
network design process. We demonstrate that MENNDL can
produce a sufficiently accurate model for a cancer pathology
task that makes predictions 16× faster than state-of-the-art
approaches. The reduced prediction time allows for more
practical deployment of deep learning to analyze both existing
cancer pathology data and new data as it is collected. We also
benchmark MENNDL showing that it can achieve 1.3 Exaflops
(mixed precision floating point operations) on Oak Ridge
National Laboratory’s Summit supercomputer–currently, the
fastest supercomputer in the world.
The key contributions of this work are:
• A 16× performance improvement in the rate of TIL clas-
sification within whole slide pathology images, achieved
by utilizing multi-objective MENNDL on Summit at
ar
X
iv
:1
90
9.
12
29
1v
1 
 [c
s.L
G]
  2
6 S
ep
 20
19
scale. This capability enables the cancer research com-
munity to analyze pathology data at an unprecedented
scale.
• A deep learning software system, MENNDL, that can use
HPC to optimize the network design and hyperparameters
for high accuracy, as well as additional objectives that
influence real-world performance, such as shorter predic-
tion times or lower energy for prediction.
• The first deep learning system operating at over 1.3
exaflops, achieved by exploiting the tensor cores on the
NVIDIA GPUs on the Summit supercomputer.
II. BACKGROUND AND RELATED WORK
Our contributions in this work are in three areas: 1) au-
tomatically annotating digital pathology images for cancer
research, 2) multi-objective optimization in deep learning, and
3) effectively utilizing HPC systems for deep learning. Thus,
we discuss the current state-of-the-art in each of those fields.
A. Tumor Infiltrating Lymphocytes Classification
The target application in this work is annotating cancer
pathology data. During the cancer diagnosis and treatment
process, a patient may have a biopsy, which produces a diag-
nostic tissue sample. Using this sample, a slide is prepared and
examined under a microscope by a pathologist to understand
both how to treat the disease and to provide a prognosis for
the patient’s future. Virtually all cancer patients undergo these
biopsies, producing large volumes of these pathology slides.
Digital pathology, or the review of digitized pathology
slides, is gaining traction in part because quantitative measure-
ments on digitized whole slide images lead to reproducible and
significantly nuanced observations. The recent FDA approval
[1] of whole slide imaging for primary diagnostic use is
leading to widespread adoption of digital whole slide imaging.
It is widely expected that within 5-10 years the great majority
of new pathology slides will be digitized. A significant feature
in these images is tumor infiltrating lymphocytes (TILs), which
are types of immune cells that move into a tumor to try to
attack the cancer. The quantification of TILs is well known
to have prognostic value in many contexts [2] [3] because
understanding patient immune response to tumors is becoming
increasingly important with the growth of cancer immunother-
apy. Features such as TILs can be quantified through image
analysis and deep learning algorithms [4], [5]. A whole slide
image will typically contain hundreds of thousands of labeled
regions, each approximately 50×50 µm. Each resulting image
is typically gigapixel in scale and encompasses 100,000 to
1,000,000 cell nuclei.
The clinical and research demand for TIL quantification
is rapidly growing [6]. TIL characterization is proving to
be clinically predictive in many disease sites. Understanding
the presence of TILs on a population level can provide a
deeper mechanistic understanding of the role of intra-tumoral
immunity in cancer progression and treatment. Pathologists
often use only high level terms such as “brisk” or “sparse”
to describe TILs. There is a strong ongoing effort to train
pathologists to provide manual estimates of TIL percentages;
however, quantitative estimates of TIL coverage in tumors are
subject to high inter-observer variability [7]. The description
of TIL spatial patterns is even more problematic. Manual
demarcation of TIL rich regions is very time consuming and
rarely carried out except on a very small number of specimens
in research settings.
In [4], a variety of deep learning methods were developed
that were able to provide quantitative estimates of TIL density
as well as to characterize patterns of TIL distribution. The
quantitative TIL characterization goes far beyond what a
pathologist can estimate by inspecting tissue. In that work,
a convolutional neural network (CNN) architecture is system-
atically optimized to carry out recognition and classification
of nuclei from pathology images. This led to the release of a
dataset consisting of TIL maps corresponding to roughly 5,000
whole slide images from The Cancer Genome Atlas (TCGA).
The work also encompassed a thorough set of analyses that
related TIL spatial patterns to a rich set of molecular immune
and tumor features. Slow prediction time is, however, a serious
drawback to the use of either the standard or hand-crafted
CNN architectures [8].
B. Multi-Objective Optimization in Deep Learning
Within the deep learning community, focus has primarily
been directed at achieving higher accuracy or lower mean
squared error for given tasks, while neglecting other factors
important to deployment, such as prediction time. Evolutionary
optimization has been leveraged in order to both design the
network topology and optimize the weights in the network
[9] [10] [11]. Building upon these prior works [12] [13]
we extend our evolutionary optimization algorithm to include
multiple objectives. In [12], their primary objectives are 1)
sparsity of the network and 2) classification accuracy. Sparse
networks typically generalize patterns better (giving higher
accuracy) and theoretically run faster. However, the authors
note that these two objectives may be conflicting. In recent
work, the most accurate networks have often been deeper,
more complex networks that require longer prediction times
[14]. At the time the work was performed, [12] showed that
evolutionary optimization outperformed other methods in the
task of face detection by achieving sparser networks with
lower classification error. Later work confirms that deeper
networks are not necessarily better and shows that shallow
networks can be made to perform just as well as deeper,
more computationally complex networks [15]. Furthermore,
while not utilizing multi-objective optimization, the work of
[16] produced similar results showing that an evolutionary
optimization approach can produce sparse networks with high
classification accuracy.
C. Deep Learning & High Performance Computing
The use of GPU-based HPC systems is increasingly popular
in the field of deep learning applications [17], partially because
they have been successfully applied to a variety of applications
and partially because deep learning applications are typically
very computationally intensive. There are three phases of
designing and using a deep learning approach for a given
dataset, and HPC can be used for any of the three phases.
These phases are 1) design, 2) training, and 3) deployment.
In the first phase, the design of the network topology and
hyperparameters are customized for the dataset. The most
common approach for this step is for the researcher who is
using the deep learning approach to hand-tune the design
of the network, typically starting from some other popular
network design and performing intuition-guided (slightly less
than random) adjustments to a variety of parameters until the
accuracy of the network is increased. It is not uncommon for
this manual process to take months. Leveraging HPC along
with supplementary machine learning techniques has been
shown to both reduce the time to solution down to hours,
as well as increase the performance of the network, often
beyond what a domain expert could achieve [18]. There have
been a variety of approaches for designing hyperparameters
for deep learning on HPC, including using support vector
machines to drive prediction of good hyperparameter sets [19],
using Bayesian optimization [20], and using genetic algorithms
[18], [21]. HPC is very well-suited to addressing this phase
of deep learning as determining the appropriate design for the
deep learning network often requires evaluating thousands to
millions of potential network designs.
In the second phase, the training of the network (i.e., the
training of the weights in the network for a particular task)
is parallelized in a variety of ways. In one approach, the
training data is passed through the network in batches with
each node working with different batches of data and sharing
weight updates. This approach is called data parallelism but
has been shown to have issues with scaling computationally
while maintaining algorithmic performance [22]. In another
approach, called model parallelism, the network’s layers can
be distributed across multiple GPUs and/or multiple nodes in
order to train the entire network as a whole [23]. However,
this approach is severely limited in its ability to scale, as deep
networks that span entire supercomputers have not yet been
shown to outperform those networks that can fit on a single
node.
In the third and final phase, once a network has been
designed and trained, it is then deployed and used to analyze
real data, called inferencing or prediction. Utilizing HPC for
prediction can be very valuable, particularly when model par-
allelism is required for very large datasets. However, because
most domain scientists do not have access to leadership-class
HPC, this is often not a practical use of deep learning on HPC.
Though there is a small, limited scope scenario in which HPC
would be useful for prediction, for broader impact, using HPC
to create a model that can rapidly and accurately classify data
on non-HPC systems is a potential breakthrough capability for
both the HPC and the scientific community.
III. METHODS
A. MENNDL
Our deep learning framework, MENNDL, relies on an
evolutionary algorithm to determine the optimal deep neu-
ral network design for a particular scientific dataset [18].
MENNDL is designed to leverage GPU-based HPC systems
to produce deep learning networks that are optimized for
scientific datasets in a quick, efficient, and automated manner.
It can be utilized on smaller scale HPC systems (e.g. an 8
GPU system) as well as larger HPC resources (e.g the Summit
supercomputer) depending on the complexity of the problem
and the desired time to solution. MENNDL optimizes the
network topology (number and type of layers), as well as the
hyperparameters of each layer in the network in order to cus-
tomize it for a particular dataset. This approach is contrasted
with the typical approach taken for scientific data, which is to
use an “off-the-shelf” network topology and hyperparameter
set and then hand-tune the topology and hyperparameters
for the dataset. This hand-tuning process can take on the
order of weeks to months for a scientist to perform. Utilizing
MENNDL and a GPU-based HPC system, this process is
automated and can take on the order of hours, while typically
achieving performance better than the network hand-tuned
by a domain expert. In a previous work, we introduced the
scalability of the original MENNDL code, demonstrating a
peak performance of 167 sustained petaflops on designing
a deep neural network for use on scanning transmission
electron microscopy data [24]. The scalability of MENNDL
relies on its asynchronous, master-worker genetic algorithm
implementation, which is used to keep as many GPUs as are
available busy evaluating candidate network designs over the
course of the evolution.
MENNDL is wrapped around a deep learning implementa-
tion framework (e.g., PyTorch, TensorFlow), which is used to
evaluate each candidate network topology and hyperparameter
set by training a network’s weights. Previous versions of the
MENNDL software were written in C++ and utilized the Caffe
framework as the deep learning backend [24]. This work uses
a new version of the MENNDL software, which is written in
Python and utilizes PyTorch as the deep learning backend.
Both Caffe and PyTorch utilize cuDNN, NVIDIA’s GPU-
accelerated library of primitives for deep neural networks.
Message Passing Interface (MPI) is used to communicate
between nodes in MENNDL, and the data is stored in a
Lightning Memory-Mapped Database (LMDB).
1) Multi-Objective MENNDL: Here, we expand on MEN-
NDL by augmenting the underlying evolutionary algorithm to
perform multi-objective optimization. Previously, MENNDL
would evolve towards optimizing the network to maximize
accuracy or some other single objective of performance, like
F1-score, on a particular task. Now, we have expanded the
evolutionary process to potentially include optimizing the fol-
lowing objectives: 1) minimizing training time, 2) maximizing
resource utilization during training, 3) maximizing accuracy
on the given dataset, 4) minimizing network size, and/or 5)
minimizing prediction time.
All of these objectives are interrelated and can potentially
affect each other. Maximizing resource utilization during train-
ing is a system-specific objective. When using Summit, the
training of each individual network utilizes one NVIDIA Volta
GPU. In this case, one definition for maximizing resource
utilization during training is to maximize the usage of the
Volta’s tensor cores. By maximizing a network’s utilization
of the tensor cores, it is likely that the training time is also
reduced. Training time and prediction time are also highly
correlated with network size, simply because smaller networks
require fewer operations in both the training and prediction
stages.
Previous work with MENNDL uses accuracy on the vali-
dation set as the fitness score in the evolutionary algorithm
to drive future model refinement and selection. With multi-
objective optimization, we include the additional objectives as
part of the fitness function. In particular, the fitness function
f of given network net, is defined as follows:
f(net) = v(net) + αm(net) (1)
where the function v gives the performance on the validation
set of a given network. The performance can be measured in
different ways, such as accuracy or F1-score on a validation
set. The function m gives the measurement of a given objective
(i.e., training time, network size, etc.), that is normalized to a
value between 0 and 1. The α parameter is a scaling factor
that can be positive or negative depending on whether the
additional objective is to be maximized or minimized. In this
work, we restrict our attention to maximizing the F1-score on
the validation set and minimizing prediction time.
2) Optimization for Faster Training: It is important to note
that the goal of MENNDL is not to produce a fully trained
model (i.e., a network that can immediately be deployed on
a particular problem), but to optimize the network design to
perform well on a particular dataset. The resulting network
design can then be trained for a longer period of time on the
dataset to produce a fully trained model. During MENNDL’s
network design evaluation process, millions of potential net-
works are evaluated, where each network is trained for a short
period of time to assess the performance of that particular
network design against a given dataset. As this is the most
computationally intensive part of MENNDL (i.e., the training
of each individual network to produce a fitness score), we
include a variety of optimizations to speed up the training
time for each individual network design.
Different network hyperparameters and topologies have rad-
ically different utilization of the tensor cores in NVIDIA Volta
GPUs and thus radically different performance characteristics.
We performed a sweep of approximately 10,000 convolution
layer hyperparameter sets to identify which configuration
maximally utilizes the tensor cores, which are specialized
hardware designed to accelerate deep learning operations.
Figure 2 highlights the top ten performing networks in terms
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Fig. 1. Network that utilizes the high-performing network hyperparameters.
Figure created using [25].
of GPU utilization or FLOP/s. As can be seen in this figure,
there are certain hyperparameters and associated values that
are correlated with a higher number of FLOP/s. In particular,
setting the number of input channels at 256, the number
of outputs at 256, the kernel size at 4, and the stride at
1 resulted in the top ten performing networks in terms of
FLOP/s, whereas batch size had relatively little impact. Using
these results, we can then bias network hyperparameters within
the MENNDL optimization towards those that have higher
utilization of the tensor cores and thus should train faster.
Using these high-performing network hyperparameters, we
have also manually constructed a network (shown in Figure 1)
that operates on the dataset described in Section III-B1, which
we use to benchmark system performance.
B. Cancer Research Application
For this work, we focus on using MENNDL to produce
a neural network capable of rapidly generating TIL charac-
terizations on commodity hardware. The need to characterize
the state of tumor immune interactions is ubiquitous given
the pivotal role played by the immune system in cancer. The
World Health Organization (WHO) International Agency for
Research on Cancer estimates that there are roughly 18 million
new cancer cases every year, predicted to increase to 21.5
million new cases by 2025. This leads to a requirement of
analyzing roughly 200 million slides per year, assuming a
conservative estimate of 10 whole slide images analyzed per
patient over the course of their disease. The results of these
analyses will be employed both in research and in clinical
care. The FDA has an active working group focusing on AI
algorithms in pathology; this group is targeting TILs as a top
priority clinical need.
Cancer registries and research organizations world-wide will
make use of tumor immune characterizations. The National
Cancer Institute Surveillance, Epidemiology, and End Results
program (SEER) (https://seer.cancer.gov/) generates crucial
epidemiological information for roughly 1/3 of all U.S. cancer
patients. SEER currently supports Stony Brook University to
develop algorithms and processes to support incorporation
of TIL data into SEER cancer registries and reports (NCI
CA225021). It is anticipated that TIL maps and specimen
and patient level summaries generated from these maps will
become crucial components of cancer epidemiological studies
performed by NCI SEER and by the research community.
At scale, the US SEER effort will involve analysis of TIL
maps for roughly 10 million whole slide images on an annual
basis. SEER data is generated locally at over 1,000 separate
health care institutions. For logistical, legal, and contractual
reasons, TIL data will also need to be generated locally. Local
health care sites are frequently poorly resourced; efficient
computation of TIL data is essential for adoption. Cancer
working groups focused on TILs are notably international
[26], [27]; the need for inexpensive locally produced TIL
predictions and resource constraints are similarly crucial in
international settings.
1) Data Description: As the training set, we used 86,000
patches that were manually annotated with TIL classification
[4]. In the full set, there are 64,381 TIL negative patches
and 21,773 TIL positive patches. All training patches used
are in 100x100 pixel resolution, 20 times magnification, and
are annotated as TIL positive or TIL negative. Examples of
the training images and their labels are given in Figure 4.
These training images represent seven different cancer types:
invasive carcinoma of the breast (BRCA), colon adenocar-
cinoma (COAD), lung adenocarcinoma (LUAD), pancreatic
adenocarcinoma (PAAD), prostate adenocarcinoma (PRAD),
skin cutaneous melanoma (SKCM), and endometrial carci-
noma of the uterine corpua (UCEC). We use another 652
patches as our validation set (all from the LUAD cancer
type), and 900 manually annotated patches from twelve cancer
types in total as the testing set. The twelve cancer types
are the seven listed above, as well as urothelial carcinoma
of the bladder (BLCA), cervical squamous cell carcinoma
and endocervical adenocarcinoma (CESC), lung squamous
cell carcinoma (LUSC), rectal adenocarcinoma (READ), and
stomach adenocarcinoma (STAD).
C. System
We performed our experiments using Oak Ridge National
Laboratory’s Summit supercomputer. Summit has 4,608 nodes,
where each node contains two IBM POWER9 CPUs and
six NVIDIA Volta GPUs, all of which are connected with
NVIDIAs high-speed NVLink. Each node has over half a ter-
abyte of coherent memory (high bandwidth memory + DDR4)
addressable by all CPUs and GPUs plus 800GB of non-volatile
RAM that can be used as a burst buffer or as extended memory.
The nodes are connected in a non-blocking fat-tree using a
dual-rail Mellanox EDR InfiniBand interconnect1. Each Volta
GPU has tensor cores available that perform mixed-precision
matrix multiply and accumulate calculations and account for
a majority of Summit’s compute capability.
1) Measuring System Performance: We measure a variety
of performance characteristics of the deep learning networks
1Summit description available here: https://www.olcf.ornl.gov/
olcf-resources/compute-systems/summit/
generated by MENNDL, including power, energy, FLOP/s,
and time for both training and prediction for each network
evaluation. We capture these values for a variety of reasons,
particularly for use in our multi-objective optimization. We
instrument the training and prediction sections of the MEN-
NDL code to capture these values. We measure time using
Python’s time library, and we capture energy and power based
on measurements from the NVIDIA System Management
Interface (nvidia-smi) command line utility.
It is worth noting that measuring overall system perfor-
mance for MENNDL has the additional difficulty that it is
evaluating different network topologies and hyperparameter
sets that have radically different performance characteristics,
as shown in Figure 2. Thus, metrics such as FLOP counts and
power usage must be measured per network. However, even
when the network topology and network hyperparameters are
fixed, there are still differences in performance. When using a
complex software stack such as MENNDL that includes third-
party software (both closed and open source) and running it on
a large-scale system such as Summit, it can also be difficult to
determine why differences in performance can occur. Figure 3
shows a distribution of measured training time per epoch when
evaluating 27,510 networks; the training operations per epoch
for these networks should be very similar, if not identical,
because they all have the same network topology and network
hyperparameters. As can be seen in the figure, there appear to
be two separate distributions of training times, one centered
around 6.35 seconds per epoch and the other around 6.7
seconds per epoch. We have not yet been able to explain why
there are two separate distributions, though we speculate that
it could be attributed to a variety of software and/or hardware
factors. However, these results indicate that, much as accuracy
is often treated as a random variable when performing hyper-
parameter optimization, factors such as inference and training
time should also be treated as random variables.
IV. RESULTS
A. Application Results and Impact
In this work, our primary focus was to use MENNDL to
produce a network that can achieve comparable performance
on the TIL identification task and achieve significantly faster
prediction times than the previous state-of-the-art. In partic-
ular, the goal is to rapidly analyze existing cancer pathology
data, such as that in the SEER program dataset (see Section
III-B), and new data that is being added daily to the collection.
To produce this network we used the new multi-objective
optimization feature of MENNDL to maximize the F1-score
and minimize prediction time.
Table I shows how the approach in this work (MENNDL
with multi-objective optimization to minimize prediction time,
labeled as MENNDL in the table) compares with the baseline
approach [4], [29], as well as an approach using an off-the-
shelf network structure (Inception) that has been hand-tuned
for this dataset. In particular, Table I reports the F1-score
and the area under the curve (AUC) of the receiver operating
characteristic (ROC) curve for each approach. We use these
Fig. 2. Parallel coordinates plot showing the results of a hyperparameter sweep for 10,000 convolution layers using tensor cores. The top ten layer configurations
are highlighted in blue. All other parameter combination lines are shown in gray. Figure created using [28].
Fig. 3. Distribution of average training time per epoch for a fixed network
topology but varying learning algorithm parameters, measured on 4,585
distinct nodes on Summit (27,510 GPUs, one network per GPU).
TABLE I
APPLICATION PERFORMANCE COMPARISON
Model Name F1-Score AUC Prediction Rate
Baseline [4], [29] 0.85 0.798 Not reported
Inception 0.87 0.899 433 patches/seconds
MENNDL (this work) 0.83 0.839 7033 patches/second
measurements rather than accuracy on the dataset because the
dataset is imbalanced.
As is noted in the table, the MENNDL network produces
comparable F1-scores and AUC as the baseline and Inception
results, but the prediction times per patch are over 16×
faster than the Inception results. Whole-slide images are
on the order of 200,000 patches; in production use one
would expect to run an ensemble of predictions using models
produced by three independently generated training sets. With
the Inception network, using a single GPU (as a laboratory,
pathologist, or researcher might have in their desktop com-
puter) would take approximately 8 minutes to classify the
TILs within an entire slide. The MENNDL-generated network
achieves comparable accuracy, but can analyze a single whole
slide image on a single GPU in roughly 30 seconds. Assuming
that three predictions are carried out, the MENNDL network
would require 1.5 minutes and the Inception network 24
minutes. Figure 5 shows a portion of a whole slide image with
and without the TIL annotations that the MENNDL network
produces.
Slide scanners require 30 seconds to a few minutes to
generate a whole slide image; the MENNDL network will
have performance roughly matched to typical scanner data
acquisition rates. Without the MENNDL network described
here, the ability to collect data far outpaces the ability to
analyze it effectively. In terms of the SEER program dataset, as
noted in Section III-B, at scale, we are interested in producing
TIL maps for roughly 10 million whole slide images on
an annual basis. As described in Section III-B, privacy and
contractual issues inhibit aggregation of whole slide image
data. Therefore, TIL maps will for the most part be generated
locally by the thousands of institutions responsible for the
generation of the SEER whole slide images. On a worldwide
basis, national cancer research and surveillance organizations
will have the same requirements for TIL maps and data
products as the SEER program. Thus, one can expect that
ultimately 100 million whole slide images will be analyzed
per year world-wide to support these cancer epidemiology
and surveillance programs, with a larger number generated
for immediate clinical use. For both the NCI SEER program
and its international counterparts, there will be tremendous
need for rapid, inexpensive local computation of TIL maps
and TIL map data products. The MENNDL generated network
described here will enable this need to be met by bringing
the rate of image analysis up to speed with the rate of image
collection.
Fig. 4. Examples from the dataset we use in this work. We include positive and negative patches from four different cancer types: BRCA, COAD, LUAD,
and SKCM.
Fig. 5. A portion of a whole slide image from a PAAD example. The top
image is the original slide, and the bottom image highlights where TILs appear
in the orange overlay, labeled using the MENNDL network.
B. Scalability
A secondary goal of the MENNDL tool is to be able to
scale to use available HPC resources to quickly produce deep
learning networks that can be practically deployed to non-HPC
resources. To demonstrate that MENNDL can utilize HPC
resources effectively, we analyze MENNDL’s performance on
Summit, the world’s fastest supercomputer.
To determine our peak sustained performance, we measured
on 4,585 nodes of Summit (the number of nodes available at
the time of our test run), for a total of 27,510 GPUs. The
measured value for our peak sustained performance is 1.301
exaflops, with an average of 47.286 teraflops per GPU, which
is approximately 38 percent of the theoretical max for Summit
when using half precision arithmetic.
Figure 6 shows our weak scaling results, in which we
increase the number of networks to evaluate as we increase
the number of nodes. We display the measured performance
in Figure 6, but we also project the performance to give upper
and lower bounds, assuming the benchmark network structure
and hyperparamters given in Figure 1, but varying the learning
hyperparameters. In particular, the upper bound is assuming
that the learning hyperparameters that produced the most
FLOP/s for that network are duplicated across all GPUs (and
that all GPUs perform identically, which, as noted in Figure 3,
may not be the case). Similarly, the lower bound is assuming
that the learning hyperparameters that generated the fewest
FLOP/s are duplicated. In general, however, the variance
across measured values is small, so MENNDL exhibits linear
weak scaling in this case. It is worth noting that if you vary
the network architecture, then the upper and lower bounds can
Fig. 6. Weak scaling results. Measured results are plotted in black/gray.
We also show the upper (purple) and lower (orange) bound on performance
by showing the scaling performance assuming the best and worst observed
network, respectively, was duplicated across all available GPUs and assuming
that all GPUs perform identically.
vary dramatically.
V. DISCUSSION AND CONCLUSION
There are important implications to cancer research com-
ing from this work. Specifically, cancer researchers continue
to study and develop new indicators to increase predictive
measures of patient outcomes. For example, research shows
that high densities of TILs correlate with favorable clinical
outcomes [30], such as overall survival and longer cancer-free
periods for multiple cancer types [3].
The use of MENNDL and HPC provides a significantly
faster way of quantitatively estimating the TIL density as well
as characterization of TIL distribution patterns. This quantita-
tive TIL characterization goes far beyond what a pathologist
can estimate by inspecting tissue. The work presented here en-
ables a high accuracy, high speed approach toward automating
these TIL characterizations for millions of images. Thus, these
images and their annotations can then be used to accelerate
cancer research.
The kind of network design optimization performed by
MENNDL is enabled in a short amount of time only through
the utilization of a high-performance computer such as Summit
because of the size of the potential solution space size. Sum-
mit’s GPU-centric heterogeneous design is ideal for quickly
evaluating different configurations of deep learning networks.
This resource provides ample compute capacity to create a
population that can sufficiently explore the hyperparameter
optimization space. Consequently, MENNDL running on HPC
platforms creates a broader application impact than previous
HPC-based deep learning approaches [23] [22]. Though we
utilize HPC in this work to reach a good solution quickly,
MENNDL can also be deployed on smaller systems, though
the time-to-solution will be significantly increased.
In this work, MENNDL was significantly enhanced with
the ability to optimize a deep learning network for multiple
design objectives. Thus, not only can a network be optimized
for accuracy on a given dataset, but also for other objectives
such as prediction time or energy usage. Training a deep
learning network that has high accuracy on a given scientific
dataset is just one step in the life cycle of a deep learning
network. In practice, the resulting network will then be used
to analyze current data and future data as it is produced.
Therefore, improvements in training time become much less
significant than reductions in prediction times. Further, reduc-
tions in prediction time and improvements in computational
performance provide the ability to analyze datasets that are
currently beyond our capability to analyze. The ability to use
HPC to produce networks that are capable of fast and accurate
predictions makes HPC a significant enabling technology in
using deep learning for scientific analysis.
Although we have restricted our attention to the particular
application of TIL identification in digital pathology images
in this work, the MENNDL approach has much broader
applicability. MENNDL tailors the network design and hy-
perparameters of the network for a given dataset, automating
and accelerating a process that is typically done manually by
scientists for each individual dataset. Pathology deep learning
applications have been rapidly emerging; examples include
pathology classification, tumor segmentation, and semantic
segmentation of cell nuclei [31], [32], [33]. We anticipate that
MENNDL-generated networks are likely to be of great value
for these applications. MENNDL has also been demonstrated
successfully on a variety of applications, including datasets
from high energy physics, small angle neutron scattering,
medical imaging [18], remote sensing [19], and scanning
transmission electron microscopy data [24]. Moving forward,
MENNDL will ease the application of deep learning to a
variety of other scientific datasets since it eliminates the burden
from the scientist to hand-tune deep learning networks to
operate on their data.
ACKNOWLEDGEMENTS
This material is based upon work supported by the U.S.
Department of Energy, Office of Science, Office of Ad-
vanced Scientific Computing Research, Robinson Pino, pro-
gram manager, under contract number DE-AC05-00OR22725
and by work supported by National Cancer Institute grants
CA225021, CA180924 and CA215109. This research used
resources of the Oak Ridge Leadership Computing Facility,
which is a DOE Office of Science User Facility supported
under Contract DE-AC05-00OR22725.
REFERENCES
[1] FDA, “Press announcements - FDA allows marketing of first whole slide
imaging system for digital pathology,” FDA News Release, April 2017.
[2] W. Herman Fridman, F. Pags, C. Sauts-Fridman, and J. Galon, “The
immune contexture in human tumours: Impact on clinical outcome,”
Nature reviews. Cancer, vol. 12, pp. 298–306, 03 2012.
[3] H. Angell and J. Galon, “From the immune contexture to the
immunoscore: the role of prognostic and predictive immune markers
in cancer,” Current Opinion in Immunology, vol. 25, no. 2, pp.
261 – 267, 2013, lymphocyte development / Tumour immunology
/ Cancer immunology: Clinical translation. [Online]. Available:
http://www.sciencedirect.com/science/article/pii/S095279151300040X
[4] J. Saltz, R. Gupta, L. Hou, T. Kurc, P. Singh, V. Nguyen, D. Sama-
ras, K. R. Shroyer, T. Zhao, R. Batiste et al., “Spatial organization
and molecular correlation of tumor-infiltrating lymphocytes using deep
learning on pathology images,” Cell reports, vol. 23, no. 1, pp. 181–193,
2018.
[5] F. Klauschen, K.-R. Mu¨ller, A. Binder, M. Bockmayr, M. Ha¨gele,
P. Seegerer, S. Wienert, G. Pruneri, S. de Maria, S. Badve et al., “Scoring
of tumor-infiltrating lymphocytes: From visual estimation to machine
learning,” in Seminars in cancer biology. Elsevier, 2018.
[6] P. Savas, R. Salgado, C. Denkert, C. Sotiriou, P. K. Darcy, M. J. Smyth,
and S. Loi, “Clinical relevance of host immunity in breast cancer: from
tils to the clinic,” Nature reviews Clinical oncology, vol. 13, no. 4, p.
228, 2016.
[7] S. K. Swisher, Y. Wu, C. A. Castaneda, G. R. Lyons, F. Yang, C. Tapia,
X. Wang, S. A. Casavilca, R. Bassett, M. Castillo et al., “Inter-
observer agreement between pathologists assessing tumor-infiltrating
lymphocytes (tils) in breast cancer using methodology proposed by the
international tils working group,” Annals of surgical oncology, vol. 23,
no. 7, pp. 2242–2248, 2016.
[8] V. Thorsson, D. L. Gibbs, S. D. Brown, D. Wolf, D. S. Bortone, T.-H. O.
Yang, E. Porta-Pardo, G. F. Gao, C. L. Plaisier, J. A. Eddy et al., “The
immune landscape of cancer,” Immunity, vol. 48, no. 4, pp. 812–830,
2018.
[9] D. J. Montana and L. Davis, “Training feedforward neural networks
using genetic algorithms,” in Proceedings of the 11th International
Joint Conference on Artificial Intelligence - Volume 1, ser. IJCAI’89.
San Francisco, CA, USA: Morgan Kaufmann Publishers Inc., 1989,
pp. 762–767. [Online]. Available: http://dl.acm.org/citation.cfm?id=
1623755.1623876
[10] J. D. Schaffer, D. Whitley, and L. J. Eshelman, “Combinations of genetic
algorithms and neural networks: a survey of the state of the art,” in
[Proceedings] COGANN-92: International Workshop on Combinations
of Genetic Algorithms and Neural Networks, June 1992, pp. 1–37.
[11] K. O. Stanley and R. Miikkulainen, “Evolving neural networks
through augmenting topologies,” Evol. Comput., vol. 10, no. 2,
pp. 99–127, Jun. 2002. [Online]. Available: http://dx.doi.org/10.1162/
106365602320169811
[12] S. Roth, A. Gepperth, and C. Igel, Multi-Objective Neural Network
Optimization for Visual Object Detection. Berlin, Heidelberg: Springer
Berlin Heidelberg, 2006, pp. 629–655.
[13] J. Liu, M. Gong, Q. Miao, X. Wang, and H. Li, “Structure learning
for deep neural networks based on multiobjective optimization,” IEEE
Transactions on Neural Networks and Learning Systems, vol. 29, no. 6,
pp. 2450–2463, June 2018.
[14] A. Canziani, A. Paszke, and E. Culurciello, “An analysis of deep neural
network models for practical applications,” CoRR, vol. abs/1605.07678,
2016. [Online]. Available: http://arxiv.org/abs/1605.07678
[15] J. Ba and R. Caruana, “Do deep nets really need to be deep?” in
Advances in Neural Information Processing Systems 27, Z. Ghahramani,
M. Welling, C. Cortes, N. D. Lawrence, and K. Q. Weinberger, Eds.
Curran Associates, Inc., 2014, pp. 2654–2662. [Online]. Available: http:
//papers.nips.cc/paper/5484-do-deep-nets-really-need-to-be-deep.pdf
[16] D. C. Mocanu, E. Mocanu, P. Stone, P. H. Nguyen, M. Gibescu,
and A. Liotta, “Scalable training of artificial neural networks with
adaptive sparse connectivity inspired by network science,” Nature
Communications, vol. 9, no. 1, p. 2383, 2018. [Online]. Available:
https://doi.org/10.1038/s41467-018-04316-3
[17] T. Ben-Nun and T. Hoefler, “Demystifying parallel and distributed
deep learning: An in-depth concurrency analysis,” CoRR, vol.
abs/1802.09941, 2018. [Online]. Available: http://arxiv.org/abs/1802.
09941
[18] S. R. Young, D. C. Rose, T. Johnston, W. T. Heller, T. P. Karnowski,
T. E. Potok, R. M. Patton, G. Perdue, and J. Miller, “Evolving deep
networks using HPC,” in Proceedings of the Machine Learning on HPC
Environments. ACM, 2017.
[19] T. Johnston, S. R. Young, D. Hughes, R. M. Patton, and D. White,
“Optimizing convolutional neural networks for cloud detection,” in
Proceedings of the Machine Learning on HPC Environments, ser.
MLHPC’17. New York, NY, USA: ACM, 2017.
[20] P. Balaprakash, M. Salim, T. Uram, V. Vishwanath, and S. Wild, “Deep-
hyper: Asynchronous hyperparameter search for deep neural networks,”
in 2018 IEEE 25th International Conference on High Performance
Computing (HiPC). IEEE, 2018, pp. 42–51.
[21] D. Martinez, W. Brewer, G. Behm, A. Strelzoff, A. Wilson, and D. Wade,
“Deep learning evolutionary optimization for regression of rotorcraft
vibrational spectra,” in 2018 IEEE/ACM Machine Learning in HPC
Environments (MLHPC). IEEE, 2018, pp. 57–66.
[22] T. Kurth, S. Treichler, J. Romero, M. Mudigonda, N. Luehr,
E. Phillips, A. Mahesh, M. Matheson, J. Deslippe, M. Fatica,
Prabhat, and M. Houston, “Exascale deep learning for climate
analytics,” in Proceedings of the International Conference for High
Performance Computing, Networking, Storage, and Analysis, ser. SC
’18. Piscataway, NJ, USA: IEEE Press, 2018, pp. 51:1–51:12.
[Online]. Available: http://dl.acm.org/citation.cfm?id=3291656.3291724
[23] B. Van Essen, H. Kim, R. Pearce, K. Boakye, and B. Chen,
“Lbann: Livermore big artificial neural network hpc toolkit,” in
Proceedings of the Workshop on Machine Learning in High-
Performance Computing Environments, ser. MLHPC ’15. New
York, NY, USA: ACM, 2015, pp. 5:1–5:6. [Online]. Available:
http://doi.acm.org/10.1145/2834892.2834897
[24] R. M. Patton, J. T. Johnston, S. R. Young, C. D. Schuman, D. D. March,
T. E. Potok, D. C. Rose, S.-H. Lim, T. P. Karnowski, M. A. Ziatdinov
et al., “167-pflops deep learning for electron microscopy: from learning
physics to atomic manipulation,” in Proceedings of the International
Conference for High Performance Computing, Networking, Storage, and
Analysis. IEEE Press, 2018, p. 50.
[25] A. LeNail, “Nn-svg: Publication-ready neural network architecture
schematics,” The Journal of Open Source Software, vol. 4, p. 747, 2019.
[26] M. V. Dieci, N. Radosevic-Robin, S. Fineberg, G. Van den Eynden,
N. Ternes, F. Penault-Llorca, G. Pruneri, T. M. DAlfonso, S. Demaria,
C. Castaneda et al., “Update on tumor-infiltrating lymphocytes (tils)
in breast cancer, including recommendations to assess tils in residual
disease after neoadjuvant therapy and in carcinoma in situ: a report of
the international immuno-oncology biomarker working group on breast
cancer,” in Seminars in cancer biology, vol. 52. Elsevier, 2018, pp.
16–25.
[27] M. Morfouace, S. Hewitt, R. Salgado, K. Hartmann, S. Litiere, S. Tejpar,
V. Golfinopoulos, T. Lively, M. Thurin, B. Conley et al., “A transatlantic
perspective on the integration of immuno-oncology prognostic and
predictive biomarkers in innovative clinical trial design,” in Seminars
in cancer biology, vol. 52. Elsevier, 2018, pp. 158–165.
[28] C. A. Steed, D. M. Ricciuto, G. Shipman, B. Smith, P. E. Thornton,
D. Wang, X. Shi, and D. N. Williams, “Big data visual analytics for ex-
ploratory earth system simulation analysis,” Computers & Geosciences,
vol. 61, pp. 71–82, 2013.
[29] L. Hou, V. Nguyen, A. B. Kanevsky, D. Samaras, T. M. Kurc, T. Zhao,
R. R. Gupta, Y. Gao, W. Chen, D. Foran et al., “Sparse autoencoder
for unsupervised nucleus detection and representation in histopathology
images,” Pattern recognition, vol. 86, pp. 188–200, 2019.
[30] B. Mlecnik, G. Bindea, F. Page`s, and J. Galon, “Tumor
immunosurveillance in human cancers,” Cancer and Metastasis
Reviews, vol. 30, no. 1, pp. 5–12, Mar 2011. [Online]. Available:
https://doi.org/10.1007/s10555-011-9270-7
[31] A. Madabhushi and G. Lee, “Image analysis and machine learning in
digital pathology: Challenges and opportunities,” 2016.
[32] L. Hou, D. Samaras, T. M. Kurc, Y. Gao, J. E. Davis, and J. H. Saltz,
“Patch-based convolutional neural network for whole slide tissue image
classification,” in Proceedings of the IEEE Conference on Computer
Vision and Pattern Recognition, 2016, pp. 2424–2433.
[33] L. Pantanowitz, A. Sharma, A. B. Carter, T. Kurc, A. Sussman, and
J. Saltz, “Twenty years of digital pathology: An overview of the road
travelled, what is on the horizon, and the emergence of vendor-neutral
archives,” Journal of pathology informatics, vol. 9, 2018.
